ESG Intelligence – Pharmaceuticals – 1st January 2021 to 30th April 2021

The Pharma sector sees its ESG perception improve, thanks to a focus on Employee Engagement and Diversity & Inclusion. The three top performing companies BI (+49), Biogen (+46), Astellas (+38) see the highest impact scores attributed in large part to Employee Engagement initiatives. Of the laggards, Affordability & Pricing dominates discussion in late-January due to multiple price hikes across the sector, and again in mid-February as several companies refuse to sell therapies at the legally required 340B price; 12 firms score negatively on this issue.